Study of new HIV infections in the Zurich area
Part of Immune system & allergy, Infections clinical trials.
This study enrolls people whose HIV infection is very recent or newly diagnosed (within the last few months). The researchers want to better understand early stages of HIV to improve how doctors identify and track new infections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a recent (newly acquired) HIV infection, typically within 6 months of the likely infection date
- Your HIV diagnosis should fit an “early” pattern (either very soon after infection or specific early lab test results)
- If you know it: your HIV “seroconversion” (first positive HIV test) must be within about 90–180 days
- If you do not know exact timing: your doctors may use early test changes plus a recent possible exposure within 180 days
- You should not have an established HIV diagnosis more than 180 days after the suspected infection date
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is an observational study that follows people to better understand how HIV and other infections (like sexually transmitted infections) happen and change over time. It may help researchers improve prevention and care, but it is mainly for monitoring rather than testing a new treatment.
This study looks at HIV in people who have just been diagnosed. It checks for drug resistance (whether the virus is resistant to certain medicines) and how the virus spreads, which can help doctors choose the best treatment for you and others.
This is an observational study (not a new drug) that tracks how living with HIV can change over time in different treatment situations. It may help researchers understand long-term effects of the modern “protease inhibitor era” and improve future care.
This study tests whether getting HIV care through a community program is as helpful as going to a clinic for people who just found out they have HIV. It looks at how well they stay in care and take their medicine.
This trial collects blood samples from people living with HIV to study dormant (inactive) HIV cells in the lab. The goal is to better understand how to target these hidden cells as part of an eventual cure.
This study follows people with a very recent HIV infection and collects blood and other samples to learn more about the infection soon after it starts. It may help researchers better understand early HIV and improve future treatments.
Hear when a new HIV Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.